Results 271 to 280 of about 15,464,746 (377)

Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs

Molecular Oncology, EarlyView.
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza, David James, Emma Creagh, James T. Murray   +3 more
wiley   +1 more source

2020 design and methods of the Population Assessment of Tobacco and Health (PATH) study during the COVID-19 pandemic. [PDF]

Tob Control
DiGaetano R, Dohrmann S, Taylor EV, Everard CD, Castleman V, Yan T, Kimmel HL, Zandberg I, Piesse A, Opsomer JD, Borek N, Silveira ML, Hubbard F, Taylor K, Creamer MR, Salim AH, Sharma E, Cheng YC, Vignare V, Cook T, Szeszel-Fedorowicz W, Siegfried Y, Carusi C, Stark D, Skara S, Hyland A.   +25 more
europepmc   +1 more source

IX.—On a small collection of lepidoptera sent from Nyasa in 1895 by Mr. R. Crawshay [PDF]

, 1896
Arthur G. Butler
openalex   +1 more source

On the collection process [PDF]

Proceedings of the American Mathematical Society, 1964
openaire   +3 more sources

Olaparib synergy screen reveals Exemestane induces replication stress in triple‐negative breast cancer

Molecular Oncology, EarlyView.
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh, Liping Su, Suet Lin Chia, Xiaohe Tian, Haslina Ahmad, Martin R. Gill   +5 more
wiley   +1 more source

Morel-Lavallée Lesion of the Hip: A Case Report. [PDF]

Cureus
Dey A, Nag P.
europepmc   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

Endoscopic Ultrasound-Guided Celiac Plexus Block-Induced Peripancreatic Abscess Requiring Transgastric Drainage. [PDF]

ACG Case Rep J
Tomar S, Pathak S, Chandan S, Abbasi A, Hayat M, Cosgrove ND, Kadkhodayan KS, Yang D, Jain D, Hasan MK, Arain MA.   +10 more
europepmc   +1 more source

Catalogue of the Conchifera or bivalve shells in the collection of the British Museum [PDF]

Gilles Deshayes
openalex   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source